These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 28583588)

  • 21. Islatravir Case Study for Enhanced Screening of Thermodynamically Stable Crystalline Anhydrate Phases in Pharmaceutical Process Development by Hot Melt Extrusion.
    Skomski D; Varsolona RJ; Su Y; Zhang J; Teller R; Forster SP; Barrett SE; Xu W
    Mol Pharm; 2020 Aug; 17(8):2874-2881. PubMed ID: 32511923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.
    Maniruzzaman M; Islam MT; Halsey S; Amin D; Douroumis D
    AAPS PharmSciTech; 2016 Feb; 17(1):191-9. PubMed ID: 26689407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-line solid state prediction during pharmaceutical hot-melt extrusion in a 12 mm twin screw extruder using Raman spectroscopy.
    Saerens L; Ghanam D; Raemdonck C; Francois K; Manz J; Krüger R; Krüger S; Vervaet C; Remon JP; De Beer T
    Eur J Pharm Biopharm; 2014 Aug; 87(3):606-15. PubMed ID: 24657540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.
    Li S; Tian Y; Jones DS; Andrews GP
    AAPS PharmSciTech; 2016 Feb; 17(1):200-13. PubMed ID: 26729536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissolution enhancement of itraconazole by hot-melt extrusion alone and the combination of hot-melt extrusion and rapid freezing--effect of formulation and processing variables.
    Lang B; McGinity JW; Williams RO
    Mol Pharm; 2014 Jan; 11(1):186-96. PubMed ID: 24283890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
    Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
    AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissolution enhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers.
    Maniruzzaman M; Rana MM; Boateng JS; Mitchell JC; Douroumis D
    Drug Dev Ind Pharm; 2013 Feb; 39(2):218-27. PubMed ID: 22452601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing Mixing Quality of a Copovidone-TPGS Hot Melt Extrusion Process with Atomic Force Microscopy and Differential Scanning Calorimetry.
    Lamm MS; DiNunzio J; Khawaja NN; Crocker LS; Pecora A
    AAPS PharmSciTech; 2016 Feb; 17(1):89-98. PubMed ID: 26283196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Hot-Melt Extrusion Processing Conditions on Physicochemical Properties of Amorphous Solid Dispersions Containing Thermally Labile Acrylic Copolymer.
    Mathers A; Hassouna F; Malinová L; Merna J; Růžička K; Fulem M
    J Pharm Sci; 2020 Feb; 109(2):1008-1019. PubMed ID: 31605688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.
    LaFountaine JS; Prasad LK; Brough C; Miller DA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):120-32. PubMed ID: 26729526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An approach for chemical stability during melt extrusion of a drug substance with a high melting point.
    Haser A; Huang S; Listro T; White D; Zhang F
    Int J Pharm; 2017 May; 524(1-2):55-64. PubMed ID: 28359810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drug.
    Lakshman JP; Cao Y; Kowalski J; Serajuddin AT
    Mol Pharm; 2008; 5(6):994-1002. PubMed ID: 19434852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
    Abu-Diak OA; Jones DS; Andrews GP
    J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of Hot Melt Extruded Solid Dispersion of Tamoxifen Citrate and Resveratrol for Synergistic Effects on Breast Cancer Cells.
    Chowdhury N; Vhora I; Patel K; Bagde A; Kutlehria S; Singh M
    AAPS PharmSciTech; 2018 Oct; 19(7):3287-3297. PubMed ID: 30218267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of mechanical and thermal energy on nifedipine amorphous solid dispersions prepared by hot melt extrusion: Preparation and physical stability.
    Ma X; Huang S; Lowinger MB; Liu X; Lu X; Su Y; Williams RO
    Int J Pharm; 2019 Apr; 561():324-334. PubMed ID: 30858115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Performance of a Highly Sensitive Model Formulation Based on Torasemide to Enhance Hot-Melt Extrusion Process Understanding and Process Development.
    Evans RC; Kyeremateng SO; Asmus L; Degenhardt M; Rosenberg J; Wagner KG
    AAPS PharmSciTech; 2018 May; 19(4):1592-1605. PubMed ID: 29488197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam-Copovidone Amorphous Solid Dispersion.
    Haser A; Cao T; Lubach JW; Zhang F
    Mol Pharm; 2018 Mar; 15(3):1226-1237. PubMed ID: 29412681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
    Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
    Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
    Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.